AHL Partners’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
Other funds holding CHE
RP
GI
VBA
AHL Partners's CHE Position: Q4 2017 in Review
AHL Partners reduced its Chemed (CHE) stake by 13% in Q4 2017, selling an estimated $1.17M and leaving 34,145 shares worth $8.3M. The position accounts for 0.13% of the portfolio, ranked #278.
AHL Partners first reported a position in CHE in Q3 2014 and has held it in 14 quarters since. The position peaked at $15.3M in Q2 2017. 299 funds tracked by Wall St. Rank hold CHE as of Q4 2017.
- AHL Partners held 34,145 shares of Chemed worth $8.3M as of Q4 2017.
- AHL Partners sold 5,140 Chemed shares in Q4 2017, an estimated $1.17M.
- Chemed made up 0.13% of AHL Partners's portfolio in Q4 2017, its #278 holding.
- AHL Partners first reported a position in Chemed in Q3 2014 and has held it in 14 quarters since.
- AHL Partners's Chemed position peaked at $15.3M in Q2 2017.
- 299 funds tracked by Wall St. Rank held Chemed as of Q4 2017.
Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.